In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Hims & Hers Health Inc (NYSE: HIMS) was $49.47 for the day, up 18.12% from the previous closing price of $41.88. In other words, the price has increased by $18.12 from its previous closing price. On the day, 156.3 million shares were traded.
Ratios:
Our analysis of HIMS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 34.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 47.03. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.59. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On February 18, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also upped its target price recommendation from $42 to $60.
Citigroup Downgraded its Neutral to Sell on January 10, 2025, whereas the target price for the stock was revised from $24 to $25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 28 ’25 when Boughton Soleil sold 3,236 shares for $30.19 per share. The transaction valued at 97,695 led to the insider holds 159,662 shares of the business.
Dudum Andrew sold 50,000 shares of HIMS for $1,819,310 on Apr 29 ’25. The Chief Executive Officer now owns 92,103 shares after completing the transaction at $36.39 per share. On Apr 28 ’25, another insider, Dudum Andrew, who serves as the Chief Executive Officer of the company, sold 41,667 shares for $30.19 each. As a result, the insider received 1,257,760 and left with 92,103 shares of the company.
Valuation Measures:
As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 72.01, and their Forward P/E ratio for the next fiscal year is 50.96. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.08. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.20 while its Price-to-Book (P/B) ratio in mrq is 20.14.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $11.45. The 50-Day Moving Average of the stock is 49.08%, while the 200-Day Moving Average is calculated to be 81.59%.
Shares Statistics:
A total of 215.21M shares are outstanding, with a floating share count of 183.36M. Insiders hold about 18.02% of the company’s shares, while institutions hold 71.34% stake in the company.
